BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1665 related articles for article (PubMed ID: 19428953)

  • 1. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
    Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
    Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
    Bartling A; Worek F; Szinicz L; Thiermann H
    Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic analysis of interactions of different sarin and tabun analogues with human acetylcholinesterase and oximes: is there a structure-activity relationship?
    Aurbek N; Herkert NM; Koller M; Thiermann H; Worek F
    Chem Biol Interact; 2010 Sep; 187(1-3):215-9. PubMed ID: 20105433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing of antidotes for organophosphorus compounds: experimental procedures and clinical reality.
    Eyer P; Szinicz L; Thiermann H; Worek F; Zilker T
    Toxicology; 2007 Apr; 233(1-3):108-19. PubMed ID: 17010492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of pentylsarin analogues with human acetylcholinesterase: a kinetic study.
    Worek F; Herkert NM; Koller M; Aurbek N; Thiermann H
    Toxicol Lett; 2009 Jun; 187(2):119-23. PubMed ID: 19429253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity.
    Calić M; Vrdoljak AL; Radić B; Jelić D; Jun D; Kuca K; Kovarik Z
    Toxicology; 2006 Feb; 219(1-3):85-96. PubMed ID: 16332406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivation and aging kinetics of human acetylcholinesterase inhibited by organophosphonylcholines.
    Worek F; Thiermann H; Szinicz L
    Arch Toxicol; 2004 Apr; 78(4):212-7. PubMed ID: 14647978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning.
    Lucić Vrdoljak A; Calić M; Radić B; Berend S; Jun D; Kuca K; Kovarik Z
    Toxicology; 2006 Nov; 228(1):41-50. PubMed ID: 16982122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase.
    Aurbek N; Thiermann H; Szinicz L; Eyer P; Worek F
    Toxicology; 2006 Jul; 224(1-2):91-9. PubMed ID: 16720069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of two new oximes in reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by organophosphate compounds: an in vitro study.
    Costa MD; Freitas ML; Soares FA; Carratu VS; Brandão R
    Toxicol In Vitro; 2011 Dec; 25(8):2120-3. PubMed ID: 21983245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons to be learnt from organophosphorus pesticide poisoning for the treatment of nerve agent poisoning.
    Thiermann H; Szinicz L; Eyer P; Felgenhauer N; Zilker T; Worek F
    Toxicology; 2007 Apr; 233(1-3):145-54. PubMed ID: 17161895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudo-catalytic scavenging: searching for a suitable reactivator of phosphorylated butyrylcholinesterase.
    Kovarik Z; Katalinić M; Sinko G; Binder J; Holas O; Jung YS; Musilova L; Jun D; Kuca K
    Chem Biol Interact; 2010 Sep; 187(1-3):167-71. PubMed ID: 20206154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in evaluation of oxime efficacy in nerve agent poisoning by in vitro analysis.
    Worek F; Eyer P; Aurbek N; Szinicz L; Thiermann H
    Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):226-34. PubMed ID: 17112559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic analysis of reactivation and aging of human acetylcholinesterase inhibited by different phosphoramidates.
    Worek F; Aurbek N; Koller M; Becker C; Eyer P; Thiermann H
    Biochem Pharmacol; 2007 Jun; 73(11):1807-17. PubMed ID: 17382909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K; Bajgar J
    Clin Toxicol (Phila); 2009 Jan; 47(1):72-6. PubMed ID: 18686075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of HI 6 treatment after percutaneous VR exposure by use of a kinetic-based dynamic computer model.
    Aurbek N; Thiermann H; Szinicz L; Worek F
    Toxicology; 2007 Apr; 233(1-3):173-9. PubMed ID: 16904808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K
    Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes.
    Worek F; Thiermann H; Szinicz L; Eyer P
    Biochem Pharmacol; 2004 Dec; 68(11):2237-48. PubMed ID: 15498514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical treatment of acute poisoning with organophosphorus and carbamate pesticides.
    Jokanović M
    Toxicol Lett; 2009 Oct; 190(2):107-15. PubMed ID: 19651196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivation kinetics of 31 structurally different bispyridinium oximes with organophosphate-inhibited human butyrylcholinesterase.
    Horn G; Wille T; Musilek K; Kuca K; Thiermann H; Worek F
    Arch Toxicol; 2015 Mar; 89(3):405-14. PubMed ID: 24912784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 84.